- Global Pharma News & Resources

Weekly Life Science News Round Up: 2nd – 6th May

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Devices sectors from 2nd – 6th May.

Gilead and Dragonfly announce strategic research collaboration to develop natural killer cell engagers in Oncology and Inflammation

Gilead Sciences and Dragonfly Therapeutics announce a collaboration designed to advance a number of Dragonfly’s novel natural killer (NK) cell engager-based immunotherapies for oncology and inflammation indications.

Pharm-Olam is now Allucent

Global biopharmaceutical services leader, CATO SMS, today unveiled its new name, Allucent with bold branding to emphasize the company’s spotlight on serving the specialized needs of small and mid-sized biotech companies.

Catalyst Clinical Research acquires Aptus Clinical to accelerate European expansion, broaden client services, and enhance patient impact

Catalyst Clinical Research announces the strategic acquisition of Aptus Clinical to expand the geographic reach of the two companies, and to enhance patient access to advanced, life-changing therapies.

ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

AVDANZ PHARMA has signed an agreement with Intercept Pharmaceuticals to acquire the majority of Intercept’s subsidiaries and operations in Europe, Canada, and all other markets outside of the U.S.

Nicoya completes acquisition of LSK Technologies, expanding digital platform into molecular testing

Nicoya Lifesciences announces the acquisition of LSK Technologies, a University of Toronto startup decentralizing laboratory testing with their high-throughput lab-in-a-box platform.

Orano acquires INEVO to develop its engineering activities in the Healthcare, Pharmaceuticals, Fine Chemicals, Biotechnology and Cosmetics sectors

The Orano Group announces the acquisition by Orano Projects of INEVO, an engineering firm specialized in process engineering and the optimization of industrial performance.

Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership

Medartis Holding AG announces that is has completed the acquisition of Nextremity Solutions Inc., a strategic commercialisation organisation located in Warsaw, USA.

Elligo launches European operations to enable research through healthcare

Elligo Health Research®, the ultimate healthcare-enabling research organization, announces a new collaboration with WHYZE Health, a digital platform that strives to unify research, healthcare, and patient data.

Matica Bio opens new cell and gene therapy GMP facility in Texas

Matica Biotechnology, Inc. announces the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.

Novotech acquires US CRO NCGS, expands global expertise

Novotech has acquired US CRO NCGS as part of its expansion program, and can now offer its biotech clients clinical services in the US to support later phase global studies.

Applications open for SmiLe’s international Biotech program with BioM and Merck

Applications are now open for Biotech Bootcamp, SmiLe’s new, international training program for future biotech entrepreneurs which is fun in full partnership with one of Europe’s leading biotechnology clusters, Bioin Germany and sponsored by Merck.

Multiply Labs adds Thermo Fisher Scientific and Charles River Laboratories to its robotic manufacturing consortium

The robotic cell therapy manufacturing Consortium founded by Multiply Labs, with initial participation from UCSF and Cytiva, announces that Thermo Fisher Scientific and Charles River Laboratories, Inc. are joining.

P360 launches ZING Engagement Suite to help pharma sales teams improve HCP engagement

P360 announces the launch of its ZING Engagement Suite, which helps pharmaceutical sales teams seamlessly engage with today’s hard-to-reach healthcare professionals (HCP) at scale.

NextGen Healthcare partners with Circuit Clinical to bolster diversity in clinical trials by extending access to underserved communities

NextGen Healthcare announces a partnership with Circuit Clinical to bring clinical trial access to patients of Federally Qualified Health Centers (FQHCs) through over 14,000 providers that utilize NextGen Healthcare solutions.

Neuraxpharm pursues growth strategy for business in Switzerland

Neuraxpham Group ignites the next level of their business in Switzerland to leverage the full potential of the important pharmaceutical market.


See more of the latest Life Science news on and PharmiWeb.Jobs.

Editor Details

Last Updated: 06-May-2022